This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
How the Industries got into Tech Debt Medical devices and custom medical processes undergo strict scrutiny to ensure quality and consumer safety. Technical debt (tech debt), referring to the deferred maintenance and upgrades of a system, is commonly accrued in the healthcare and lifesciencesindustries.
Rather than try to innovate from within healthcare, there are opportunities to disrupt the model by bringing proven solutions and innovations from other industries into healthcare. Larger companies tend to be less self-disruptive and, therefore, less innovative. But here too is where the opportunity lies.
The funds will be used to accelerate the development of Lavita’s AI-first platform and applications for patients, healthcare providers, and research institutions. Lavita platform will enable numerous applications within lifescience research, biopharma development, and healthcareinnovation. kkhadvisors.com
BOSTON and SEATTLEMarch 25, 2025 Xealth , the leader in digital health enablement for health systems, today announced a strategic investment from Morningside Ventures , a leading investor in healthcareinnovation. We are thrilled to work with Morningside Ventures.”
BERLIN – October 7, 2024 – EVERSANA , a leading provider of global commercial services to the lifesciencesindustry, today announced the continued growth of its European footprint with a new office in Berlin, Germany, Europe’s largest pharmaceutical market.
To get you the best advice, we reached out to our brilliant Healthcare IT Today Community to share their insights on these two points. First, is your solution unique or differentiated enough compared to what’s in the industry? The third is industry trends – where is the money flowing in healthcare?
More care-at-thome options, the desire to have care delivery in non-traditional settings and the COVID-19 pandemic are driving healthcareinnovations. population being managed for chronic diseases, RPM is an innovation that can reduce healthcare costs with more timely and efficient care. THE LARGER TREND. ON THE RECORD.
This new fund underscores the firm’s continued commitment to driving innovation and elevating health globally through investments in digital health, medical devices, lifesciences, and tech-enabled care delivery. For more information about SpringTide Ventures, visit: [link]. For more information, visit [link].
The following is a guest article by Mike Hale, Principal Solutions Engineer at EchoStor The healthcareindustry finds itself in an increasingly precarious position. The statistics paint a stark picture of healthcare’s cybersecurity crisis. Healthcare data breaches cost an average of $10.93
The following is a guest article by Ganesh Nathella, Senior Vice President & General Manager – Healthcare and LifeSciences Business at Persistent Systems The rapid integration of digital technologies in healthcare has revolutionized patient care and operations, but it has also heightened concerns about data privacy.
Flywheel’s products transform healthcareinnovation by empowering organizations to efficiently and securely ingest, curate and share medical imaging data for accelerated research and AI development,” said Flywheel CEO, Jim Olson. Faegre Drinker Biddle & Reath LLP served as counsel to Flywheel in connection with the financing.
Visit www.nelsonadvisors.co.uk Scotland's history of medical and healthcareinnovation For more than 200 years, Scotland’s scientific discoveries have served as critical stepping stones for the advancement of modern medicine. These initiatives are helping to create a supportive environment for healthtech companies to thrive.
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital LifeScience. Solas puts patients first.
Smile’s HDF platform uses industry-leading HDF architecture and ONC-compliant, event-driven FHIR APIs to allow healthcare providers, payers and IT vendors to build secure, composable and scalable data infrastructures. Smile Digital Health has seen significant growth in our platform because it does just this.
Similarly, Brad’s deep industry understanding and background in health insurance and venture capital equips us with a robust foundation for managing complex investments and navigating the nuances of early-stage healthcare.” For more information, visit [link].
With this funding, we’ll be able to continue driving innovation in conversational intelligence and machine learning to streamline the patient journey and help staff do their best work.”. Unsolicited customer feedback is a valuable resource for healthcare and lifescience organizations.
This first-of-its-kind event is being hosted by the Department of Health – Abu Dhabi and aims to be a landmark platform for international collaboration on the future of healthcare and lifesciences. The Abu Dhabi Global Healthcare Week (ADGHW) doesn't have much of a history yet, as it's a brand new event!
Berlin has proven itself as a thriving ecosystem for healthcareinnovation and boasts of 35 large research institutes and universities focusing on lifesciences, including internationally renowned institutions as well as a vibrant start-up scene.
The JP Morgan Healthcare Conference, often referred to simply as ‘JPM’, ‘JPM Week’, or ‘JPM Healthcare’, is an annual event that is considered one of the largest and most influential gatherings in the healthcare and lifesciencesindustry. The main JPM Healthcare Conference takes place at The Westin St.
HIC joins over 15 of the UK’s leading HealthTech companies heading stateside to forge export collaborations and showcase the excellence of the UK’s health technology industry. For more information, visit: [link] About ABHI ABHI is the UK’s leading industry association for health technology (HealthTech).
HealthcareInnovation Consortium (HIC) – a leading UK-based digital health and social care agency – is launching a new programme aimed at combatting antimicrobial resistance (AMR) at Global Health 2023.
The new programme targeting AMR, led by HealthcareInnovation Consortium in collaboration with Mecomed and Barts LifeSciences , is targeting healthtech innovators in the UK, Ireland and Middle East with solutions that can directly address AMR or be adapted to do so.
“Combining Miromatrix’s pioneering bioengineered organ technology with Baxter’s expertise in critical care delivery and industry-leading PrisMax system has the potential to transform care for ALF patients.” About Miromatrix Miromatrix Medical Inc. To learn more, visit www.baxter.com and follow us on Twitter , LinkedIn and Facebook.
Exec Summary: Corporate venture capital (CVC) plays an increasingly significant role in the healthtech industry, providing funding, expertise, and strategic partnerships to innovative startups. This gives them a better understanding of the needs and challenges of healthcare providers and patients. Visit www.nelsonadvisors.co.uk
As he describes it, WEGO Health is working with clients in the lifesciences – including pharma, digital health startups and others – to bring patient voice and expertise into their organizations in order to build more patient-centered solutions. I, for one, hope that we don’t have to wait five years.
As he describes it, WEGO Health is working with clients in the lifesciences – including pharma, digital health startups and others – to bring patient voice and expertise into their organizations in order to build more patient-centered solutions. I, for one, hope that we don’t have to wait five years.
As he describes it, WEGO Health is working with clients in the lifesciences – including pharma, digital health startups and others – to bring patient voice and expertise into their organizations in order to build more patient-centered solutions. I, for one, hope that we don’t have to wait five years.
As he describes it, WEGO Health is working with clients in the lifesciences – including pharma, digital health startups and others – to bring patient voice and expertise into their organizations in order to build more patient-centered solutions. I, for one, hope that we don’t have to wait five years.
As he describes it, WEGO Health is working with clients in the lifesciences – including pharma, digital health startups and others – to bring patient voice and expertise into their organizations in order to build more patient-centered solutions. I, for one, hope that we don’t have to wait five years.
The blue chips of Silicon Valley have announced they’re interested in disrupting an industry that has bedeviled us with rising costs and inefficiencies for decades. This summer, Apple opened Health Records API to health IT innovators to enable them to create apps that utilize the data. That is more than any tech firm except Apple.
As a digital healthcareinnovator, why do I care? Because the pervasive cloud wars have morphed into AI wars, and they’re coming for healthcare. When new technology achieves pop-culture relevance , we gain from the momentum in every industry, including healthcare. In the space of a month, Bing gained legitimacy.
BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. Advent International and Warburg Pincus have extensive experience helping innovativehealthcare companies advance their mission and strategic priorities.
LOS ANGELES–(BUSINESS WIRE)– Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused singularly on early-stage (primarily seed) healthcare disruptors, is continuing its mission for healthcareinnovation with the announcement of its 2023 Council of Strategic Advisors.
We expect 2023 to be a pivotal year for the industry, as the accelerated acceptance of virtual care and demographic trends, such as an aging population, increasing chronic illnesses and healthcare worker shortages, sustain demand for medtech-enabled solutions. Continued interest by private equity and other financial sponsors.
Book Care with One Click: As technology advances across industries, people are seeking the same convenient booking processes in healthcare that they are accustomed to with other services. Those two trends have existed in a false dichotomy where healthcare organizations are either looking at population-level metrics (e.g.,
From desktop computers to tablets, this technology has become essential in modern healthcare, improving the ability to manage patient data, enhance communication, and increase efficiency. But with the rise of Artificial Intelligence (AI), it is clear that supercomputing is poised to become a new backbone of healthcareinnovation.
“Now the new vision for healthcare is not just about access, quality, and affordability but also about predictive, preventive, and outcomes-based care models promoting social and financial inclusion,” says Kamaljit Behera, transformational health industry analyst at Frost & Sullivan, and author of the report. Digital therapeutics.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content